F. Fakhouri, V. Frémeaux-bacchi, L. H. Noël, H. T. Cook, and M. C. Pickering, C3 glomerulopathy: a new classification, Nat Rev Nephrol, vol.6, pp.494-499, 2010.

J. Hou, G. S. Markowitz, A. S. Bomback, G. B. Appel, L. C. Herlitz et al., Toward a working definition of C3 glomerulopathy by immunofluorescence, Kidney Int, vol.85, pp.450-456, 2014.

M. C. Pickering, D. 'agati, V. D. Nester, C. M. Smith, R. J. Haas et al., C3 glomerulopathy: consensus report, vol.84, pp.1079-1089, 2013.

S. Sethi and F. C. Fervenza, Membranoproliferative glomerulonephritisa new look at an old entity, N Engl J Med, vol.366, pp.1119-1131, 2012.

S. Sethi, F. C. Fervenza, Y. Zhang, S. H. Nasr, N. Leung et al., Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement, Clin J Am Soc Nephrol, vol.6, pp.1009-1017, 2011.

N. S. Merle, S. E. Church, V. Fremeaux-bacchi, and L. T. Roumenina, Complement System Part I -Molecular Mechanisms of Activation and Regulation, Front Immunol, vol.6, 2015.

N. S. Merle, R. Noe, L. Halbwachs-mecarelli, V. Fremeaux-bacchi, and L. T. Roumenina, Complement System Part II: Role in Immunity. Front Immunol, vol.6, 2015.

G. B. Appel, H. T. Cook, G. Hageman, J. C. Jennette, M. Kashgarian et al., Membranoproliferative glomerulonephritis type II (dense deposit disease): an update, J Am Soc Nephrol, vol.16, pp.1392-1403, 2005.

A. Servais, L. H. Noël, L. T. Roumenina, L. Quintrec, M. Ngo et al., Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies, Kidney Int, vol.82, pp.454-464, 2012.

M. A. Dragon-durey, C. Blanc, M. C. Marinozzi, R. A. Van-schaarenburg, and L. A. Trouw, Autoantibodies against complement components and functional consequences, Mol Immunol, vol.56, pp.213-221, 2013.

T. H. Goodship, I. Y. Pappworth, T. Toth, M. Denton, K. Houlberg et al., Factor H autoantibodies in membranoproliferative glomerulonephritis, vol.52, pp.200-206, 2012.

D. P. Gale, E. G. De-jorge, H. T. Cook, R. Martinez-barricarte, A. Hadjisavvas et al., Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis, Lancet, vol.376, pp.794-801, 2010.

R. Martínez-barricarte, M. Heurich, F. Valdes-cañedo, E. Vazquez-martul, E. Torreira et al., Rodríguez de Córdoba S: Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation, J Clin Invest, vol.120, pp.3702-3712, 2010.

L. T. Roumenina, C. Loirat, M. A. Dragon-durey, L. Halbwachs-mecarelli, C. Sautes-fridman et al., Alternative complement pathway assessment in patients with atypical HUS, J Immunol Methods, vol.365, pp.8-26, 2011.

S. C. Satchell, C. H. Tasman, A. Singh, L. Ni, J. Geelen et al., Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF, Kidney Int, vol.69, pp.1633-1640, 2006.

L. T. Roumenina, M. Jablonski, C. Hue, J. Blouin, J. D. Dimitrov et al., Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome, vol.114, pp.2837-2845, 2009.

M. Frimat, F. Tabarin, J. D. Dimitrov, C. Poitou, L. Halbwachs-mecarelli et al., Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-292, 2013.

M. C. Marinozzi, L. Vergoz, T. Rybkine, S. Ngo, S. Bettoni et al., Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?, J Am Soc Nephrol, vol.25, pp.2053-2065, 2014.

L. T. Roumenina, M. Frimat, E. C. Miller, F. Provot, M. A. Dragon-durey et al., Fremeaux-Bacchi V: A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function, Blood, vol.119, pp.4182-4191, 2012.

F. Forneris, D. Ricklin, J. Wu, A. Tzekou, R. S. Wallace et al., Structures of C3b in complex with factors B and D give insight into complement convertase formation, Science, vol.330, pp.1816-1820, 2010.

E. Torreira, A. Tortajada, T. Montes, R. De-córdoba, S. Llorca et al., 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase, Proc Natl Acad Sci U S A, vol.106, pp.882-887, 2009.

E. Torreira, A. Tortajada, T. Montes, R. De-córdoba, S. Llorca et al., Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase, J Immunol, vol.183, pp.7347-7351, 2009.

J. Wu, Y. Q. Wu, D. Ricklin, B. J. Janssen, J. D. Lambris et al., Structure of complement fragment C3b-factor H and implications for host protection by complement regulators, Nat Immunol, vol.10, pp.728-733, 2009.

B. D. Persson, N. B. Schmitz, C. Santiago, G. Zocher, M. Larvie et al., Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens, PLoS Pathog, vol.6, p.1001122, 2010.

J. D. Becherer and J. D. Lambris, Identification of the C3b receptor-binding domain in third component of complement, J Biol Chem, vol.263, pp.14586-14591, 1988.

B. J. Janssen and P. Gros, Structural insights into the central complement component C3, Mol Immunol, vol.44, pp.3-10, 2007.

A. E. Oran and D. E. Isenman, Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35)

, J Biol Chem, vol.274, pp.5120-5130, 1999.

T. C. Farries, T. Seya, R. A. Harrison, and J. P. Atkinson, Competition for binding sites on C3b by CR1, CR2, MCP, factor B and factor H, Complement Inflamm, vol.7, pp.30-41, 1990.

J. D. Lambris, Z. Lao, T. J. Oglesby, J. P. Atkinson, C. E. Hack et al., Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component, J Immunol, vol.156, pp.4821-4832, 1996.

S. Bruneau, M. Neel, L. T. Roumenina, M. Frimat, L. Laurent et al., Loss of DGK« induces endothelial cell activation and death independently of complement activation, Blood, vol.125, pp.1038-1046, 2015.

P. Roversi, S. Johnson, J. J. Caesar, F. Mclean, K. J. Leath et al., Structural basis for complement factor I control and its disease-associated sequence polymorphisms, Proc Natl Acad Sci U S A, vol.108, pp.12839-12844, 2011.

V. Fremeaux-bacchi, F. Fakhouri, A. Garnier, F. Bienaimé, M. A. Dragon-durey et al., Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin J Am Soc Nephrol, vol.8, pp.554-562, 2013.

V. Frémeaux-bacchi, E. C. Miller, M. K. Liszewski, L. Strain, J. Blouin et al., Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome, Blood, vol.112, pp.4948-4952, 2008.

M. Noris, J. Caprioli, E. Bresin, C. Mossali, G. Pianetti et al., Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype, Clin J Am Soc Nephrol, vol.5, pp.1844-1859, 2010.

E. C. Schramm, L. T. Roumenina, T. Rybkine, S. Chauvet, P. Vieira-martins et al., Fremeaux-Bacchi V: Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome, Blood, vol.125, pp.2359-2369, 2015.

M. D. Kazatchkine, D. T. Fearon, M. D. Appay, C. Mandet, and J. Bariety, Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus, J Clin Invest, vol.69, pp.900-912, 1982.

S. Moll, S. Lange, M. J. Mihatsch, Z. Dragic, J. A. Schifferli et al., CRIT is expressed on podocytes in normal human kidney and upregulated in membranous nephropathy, Kidney Int, vol.69, 1961.

S. Moll, S. Miot, S. Sadallah, F. Gudat, M. J. Mihatsch et al., No complement receptor 1 stumps on podocytes in human glomerulopathies, Kidney Int, vol.59, pp.160-168, 2001.

S. Ichida, Y. Yuzawa, H. Okada, K. Yoshioka, and S. Matsuo, Localization of the complement regulatory proteins in the normal human kidney, Kidney Int, vol.46, pp.89-96, 1994.

S. Sethi, F. C. Fervenza, Y. Zhang, L. Zand, J. A. Vrana et al., C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up, Kidney Int, vol.82, pp.465-473, 2012.

S. Sethi, J. D. Gamez, J. A. Vrana, J. D. Theis, . Bergen-hr-3rd et al., Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway, Kidney Int, vol.75, pp.952-960, 2009.

K. L. Rose, D. Paixao-cavalcante, J. Fish, A. P. Manderson, T. H. Malik et al., Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice, J Clin Invest, vol.118, pp.608-618, 2008.

J. Zuber, F. Fakhouri, and L. T. Roumenina,

, French Study Group for aHUS/C3G: Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat Rev Nephrol, vol.8, pp.643-657, 2012.

Y. Zhang, C. M. Nester, D. G. Holanda, H. C. Marsh, R. A. Hammond et al., Soluble CR1 therapy improves complement regulation in C3 glomerulopathy, J Am Soc Nephrol, vol.24, pp.1820-1829, 2013.

V. Frémeaux-bacchi, L. Weiss, C. Demouchy, A. May, S. Palomera et al., Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity, Nephrol Dial Transplant, vol.9, pp.1747-1750, 1994.

C. Blanc, L. T. Roumenina, Y. Ashraf, S. Hyvärinen, S. K. Sethi et al., Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome, J Immunol, vol.189, pp.3528-3537, 2012.

Q. Chen, D. Müller, B. Rudolph, A. Hartmann, E. Kuwertz-bröking et al., Combined C3b and factor B autoantibodies and MPGN type II, N Engl J Med, vol.365, pp.2340-2342, 2011.

B. J. Janssen, A. Christodoulidou, A. Mccarthy, J. D. Lambris, and P. Gros, Structure of C3b reveals conformational changes that underlie complement activity, Nature, vol.444, pp.213-216, 2006.

S. H. Rooijakkers, J. Wu, M. Ruyken, R. Van-domselaar, K. L. Planken et al., Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor, Nat Immunol, vol.10, pp.721-727, 2009.

L. T. Roumenina, R. Roquigny, C. Blanc, N. Poulain, S. Ngo et al., Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS), Methods Mol Biol, vol.1100, pp.237-247, 2014.

P. Sánchez-corral, C. González-rubio, R. De-córdoba, S. López-trascasa, and M. , Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H, Mol Immunol, vol.41, pp.81-84, 2004.

V. P. Ferreira, A. P. Herbert, C. Cortés, K. A. Mckee, B. S. Blaum et al., The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome, J Immunol, vol.182, pp.7009-7018, 2009.

M. A. Saleem, M. J. O'hare, J. Reiser, R. J. Coward, C. D. Inward et al., Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression, J Am Soc Nephrol, vol.13, pp.630-638, 2002.

D. E. Isenman, D. I. Kells, N. R. Cooper, H. J. Müller-eberhard, and M. K. Pangburn, Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties, Biochemistry, vol.20, pp.4458-4467, 1981.

K. Li, J. Gor, and S. J. Perkins, Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3, Biochem J, vol.431, pp.63-72, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00517253

N. Nishida, T. Walz, and T. A. Springer, Structural transitions of complement component C3 and its activation products, Proc Natl Acad Sci U S A, vol.103, 2006.

M. K. Pangburn, R. D. Schreiber, and H. J. Müller-eberhard, Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3, J Exp Med, vol.154, pp.856-867, 1981.

E. Rodriguez, R. Nan, K. Li, J. Gor, and S. J. Perkins, A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism, J Biol Chem, vol.290, pp.2334-2350, 2015.

M. S. Winters, D. S. Spellman, and J. D. Lambris, Solvent accessibility of native and hydrolyzed human complement protein 3 analyzed by hydrogen/ deuterium exchange and mass spectrometry, J Immunol, vol.174, pp.3469-3474, 2005.